Concepedia

Burcu Temizoz

BT

Statistics

Publications

13

Citations

532

H-Index

13

Active since

2014

Affiliations

The University of Osaka(Current)

National Institute of Biomedical Innovation, Health and Nutrition

The University of Tokyo

Yokohama City University

Hyogo Medical University

Burcu Temizoz is an author at The University of Osaka specializing in medicine, immunology, and t cell immunity.

ORCID

Top concepts

Publications per year

2014–2024

13

Publications

13

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

Burcu Temizoz, Etsushi Kuroda, Keiichi Ohata et al. · European Journal of Immunology · 2014 · 145 citations · Full text

Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation

Etsushi Kuroda, Koji Ozasa, Burcu Temizoz et al. · Immunity · 2016 · 134 citations · Full text

, , +12

Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor

Koji Ozasa, Burcu Temizoz, Takato Kusakabe et al. · Frontiers in Immunology · 2019 · 55 citations · Full text

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study

Tomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara et al. · BMC Cancer · 2022 · 26 citations · Full text

Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells

Yuji Kitahata, Tomohiro Kanuma, Masayuki Hayashi et al. · Oncotarget · 2016 · 25 citations · Full text

1–5 of 13